PROJECTS
NOW RECRUITING
The Future of Psychedelic-Assisted Cancer Care
1
2
Are You...
-
A person living with or beyond cancer?
-
A caregiver supporting someone with cancer?
-
A clinician working in oncology from any discipline?
-
A healthcare policymaker?
If yes, and you are
18 years or older
& residing in Canada,
we want to hear from you!
Take this short 15-minute survey and help us guide the future of research in Psychedelic-Assisted Cancer therapies
CAN-PACT (Canadian Network for Psychedelic-Assisted Cancer Therapy) is inviting specific voices to take part in a short survey to help identify the top unanswered questions about psychedelic-assisted cancer therapies. To learn more about what this survey will contribute to, continue reading about the JLA Alliance Priority Setting Partnership below!
James Lind Alliance (JLA) Priority Setting Partnership (PSP)
-
The James Lind Alliance (JLA) brings together patients, caregivers, and healthcare professionals to find out what research questions matter most to them.
-
Instead of researchers deciding what to study, the JLA makes sure that the people most affected by a health condition have a real voice.
-
Through a fair and transparent process, the JLA helps groups identify and rank the top unanswered questions about treatments and care. These "Top 10 Priorities" guide future research so it meets real-world needs.
At CAN-PACT, we’re using the JLA’s proven approach to make sure our research focuses on what matters most to people living with advanced cancer.
Interested in Learning More about JLA?
01
What does the JLA process look like?
-
Build a team of patients, caregivers, and clinicians.
-
Gather important unanswered questions.
-
Refine and review the questions.
-
Vote on the most important issues.
-
Create a “Top 10” research priority list.
03
How long does it take?
Most groups complete the process in about 12 to 18 months.
02
Why is it important?
It makes sure that research focuses on real-life needs — not just what scientists think is important.